This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Mary Maluccio: Innovator in Cancer Prevention
Introduction
Mary Maluccio is a notable inventor based in New York, NY (US). She has made significant contributions to the field of medical research, particularly in the area of cancer prevention. Her innovative work focuses on the use of angiotensin II inhibitors to combat malignancies associated with immunosuppression.
Latest Patents
Mary Maluccio holds 1 patent for her invention titled "Use of angiotensin II inhibitors to prevent malignancies associated with immunosuppression." This invention provides a method for reducing the formation or progression of neoplasms in mammals undergoing immunosuppressive therapy. The method involves treating the mammal with an effective amount of an angiotensin II inhibitor. Additionally, the invention outlines a method for preventing or treating neoplasms without the use of chemotherapy or radiation therapy. It also includes compositions that combine angiotensin II inhibitors with immunosuppressive agents such as cyclosporin or FK506. The angiotensin II inhibitors described in her patent encompass proteins and polypeptides that bind to angiotensin II receptors, as well as anti-angiotensin II antibodies.
Career Highlights
Mary Maluccio has established herself as a prominent figure in her field through her innovative research and patent contributions. Her work has the potential to significantly impact the treatment and prevention of cancer in patients receiving immunosuppressive therapy.
Collaborations
Mary collaborates with Manikkam Suthanthiran, who is also involved in research related to her innovative work.
Conclusion
Mary Maluccio's contributions to the field of cancer prevention through her innovative use of angiotensin II inhibitors highlight her role as a leading inventor. Her work not only advances medical research but also offers hope for improved treatment options for patients.